<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:department>Microbial &amp; Cellular Sciences</gtr:department><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6E7C5B2E-4543-45D9-A443-6E40F0A56361"><gtr:id>6E7C5B2E-4543-45D9-A443-6E40F0A56361</gtr:id><gtr:firstName>Johnjoe</gtr:firstName><gtr:surname>McFadden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/982CD1FC-56AF-4E27-9257-DF8625DCA543"><gtr:id>982CD1FC-56AF-4E27-9257-DF8625DCA543</gtr:id><gtr:firstName>Dany</gtr:firstName><gtr:otherNames>Justine Venetia</gtr:otherNames><gtr:surname>Beste</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FM026434%2F1"><gtr:id>87F2037E-5924-419B-ADE3-38CB162BD3E7</gtr:id><gtr:title>Newton001: Identification of host and pathogen glucose metabolism modulation during Mycobacterium leprae infection of human macrophages and Schwann ce</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M026434/1</gtr:grantReference><gtr:abstractText>According to World Health Organization, the number of leprosy new cases in 2012 stood at 189,018 around the world. Although not fatal, leprosy is responsible for more than 12 thousands cases of irreversible motor disability and deformity per year in the world. The disease is caused by the Mycobacterium leprae, an obligatory intracellular pathogen that preferentially infects skin macrophages and Schwann cells causing nerve damage and scarring, which results in the disfigurement and the classic hand and foot deformities of leprosy. Brazil has 33,303 cases/year of leprosy, being the most affected country in Latin America, representing 14 percent of the global number of cases and is surpassed only by India, which has approximately 134,752 new cases per year. 

Intracellular bacteria must obtain nutrients from their host cell and grow by either adapting their own metabolic pathways or manipulating the metabolism of the host. Understanding how they obtain nutrients from their host and how they utilize them will lead to better understanding the infection and may inspire novel ways to grow the bacteria for vaccine or drug studies; which is particularly relevant to the leprosy bacillus which cannot be grown in pure culture in the laboratory.

In this project we will use a newly-developed developed technique called 13C flux spectral analysis to investigate the metabolism of M. leprae in its host cell. The M. leprae cells will be grown in mouse footpads, and then incubated in media containing a mixture of 12C and 13C-labelled glucose and metabolites extracted for analysis. We will use another technique called mass spectrometry to determine the distribution of 12C and 13C carbon in these metabolites and computer analysis of the data will reveal clues to both the nutrients used by M. leprae and how it utilises them. The work will be published in a peer-reviewed journal and may lead to novel approaches to growing the leprosy bacillus and developing new drugs.</gtr:abstractText><gtr:technicalSummary>Live M. leprae will be prepared from the footpads of athymic nu/nu mice after six-nine months of infection and homenized. THP-1 human monocytes and ST8814 human Schwann cell lines will be kept at 37C or 33C (when infected) within a humidified 5% CO2 atmosphere and differentiated. Cultures will be infected with a MOI of 50:1 for 48hs. After the infection, cells will be washed with ice-cold PBS before being lysed with 0.1% Triton X-100. The supernatant containing the intracellular M. leprae and the soluble host material will be centrifuged at 4,000 x g for 20 min at 40C to pellet the bacteria, metabolites extracted and sent for mass spectrometry analysis. 
An isotopomer network model of the central metabolism of M. leprae will be constructed, and carbon exchange between the macrophage or Schwann cell environment and M. leprae will be modelled. A biomass formula will be generated to constrain metabolic flux rates. To reveal potential carbon sources (as isotopomers) for the intracellular mycobacterial cell, a multistage sampling-based C13-MFA-type approach will be implemented. The measured labelling patterns of macrophage and Schwann cells amino acids will be deconvoluted by generating random isotopomer labeling patterns for each potential substrate imitating the measured isotopologues and used to constrain the fluxes in each reaction of the model. We will therefore determine likely substrates that the leprosy bacillus obtains from its host tcell and the metabolic pathways utilized.</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-01-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>67574</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oswaldo Cruz Foundation (Fiocruz)</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Fiocruz, Brazil</gtr:description><gtr:id>B6E21B9B-3794-40D5-8EEA-33823B5D5252</gtr:id><gtr:impact>multidiciplinary involving:
microbiology
systems biology</gtr:impact><gtr:outcomeId>58c1743107bd38.46994542-1</gtr:outcomeId><gtr:partnerContribution>Our partner grew the leprosy bacillus in the athymic nu/nu mouse model. They are one of the few laboratories in the world that have this model available. They purified the leprosy bacilli and lyzed the cells and, after confiming microbiological safety, they sent the cell extracts for analysis in our laboratory.</gtr:partnerContribution><gtr:piContribution>Our partner in Brazil has prepared leprosy bacillus homogenates which we have analyzed by mass spectrometry to determine metabolic fluxes in the pathogen.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MR/M026434/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>